AVO
AVO
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
2
$1.73M
Total Volume
$1.73M
2 transactions
Net Activity
$1.73M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
No Recent Signal
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Barnard Stephen J
Exec COB
$1.73M total
Quick Actions
AVO has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at AVO (AVO) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 2 were sales. The total volume of insider trading reached $1.73M.
The net insider activity for AVO shows a net selling bias of $1.73M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Barnard Stephen J (Exec COB), who traded 111.4K shares valued at $1.45M on Sep 21, 2026.
Mission Produce (AVO) Stock Could Trade At A Discount To Fair Value
AVO - Mission Produce Inc Stock Price and Quote
Should Investors Buy, Hold or Sell AVO Stock at Its Current Valuation?
Mission Produce (AVO) Stock Looks Undervalued Even After Its Calavo Deal
Mission Produce vs. Dole: Which Stock Offers the Better Risk-Reward?
Mission Produce, Inc. (NASDAQ:AVO) Stock Has Average Target Price of $16.00 According to Analysts
Related News & Analyst Reports
Read original insights and educational research covering AVO and the Unknown sector.
Tracking Insider Activity in Biotech: High Stakes and Hidden Signals
Biotech insiders possess unique asymmetric information, clinical results, FDA feedback, partnership negotiations. This guide explains how to track Form 4 activity at pre-commercial biotechs, what position sizes matter, and how to avoid false signals near data events.
Safe Trading Practices: How to Use Insider Data Responsibly and Legally
A comprehensive guide to understanding the legal boundaries of using publicly disclosed insider trading data, best practices for avoiding common mistakes, risk management principles, and how to integrate SEC filings into a disciplined, compliant investment process.
FAQs About AVO Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for AVO.